Navigation Links
9.8% CAGR for Oligonucleotide Synthesis Market Globally to 2019 Says a New Research Report Available at RnRMarketResearch.com
Date:9/1/2014

(PRWEB) September 01, 2014

The global oligonucleotide synthesis market is expected to reach $1,712.1 million by 2019 from $1,070.7 million in 2014, growing at a CAGR of 9.8% from 2014 to 2019. The global oligonucleotide synthesis market is categorized on the basis of products and services, applications, end users, and geography. The synthesized oligonucleotides segment is expected to register the highest growth rate in the oligonucleotide synthesis market during the forecast period, owing to an increasing number of applications for synthesized oligonucleotides in research, diagnostics and therapeutics; and a growing demand for custom oligos. Complete report is available at http://www.rnrmarketresearch.com/oligonucleotide-synthesis-market-by-product-services-equipment-reagent-primer-probe-custom-oligos-end-user-research-pharmaceutical-biotechnology-application-diagnostics-pcr-qpcr-gen-market-report.html .

Major factors contributing to growth of the oligonucleotide synthesis market include growing R&D expenditure in pharmaceutical and biotech companies; emerging applications of oligos in molecular diagnostics and synthetic biology; and evolving significance of RNA-interference oligos in therapeutics and diagnostics. Furthermore, government support and venture capital funding are other major factors that will boost the growth of this market. For instance, the U.S. National Institutes of Health (NIH) spend $1.5 billion per year to support their oligonucleotide-based applications. Further, in January 2013, Solstice Biologics, a South California start-up, raised $18 million in a series-A financing backed by venture capital funding for targeting and delivery of nucleic acid therapeutics. The relatively-untapped markets of the Asia-Pacific (APAC) region and the increasing R&D activities and funding there have opened up an array of opportunities for the oligonucleotide synthesis market. However, factors such as regulatory barriers, especially for therapeutic oligos, and downward pricing pressure may restrain the growth of this market.

The leading players of this industry include Bioautomation Corporation, Biosearch Technologies, Inc, Eurofins Genomics (A Subsidiary of Eurofins Scientific Group), Eurogentec (A Subsidiary of Kaneka Corporation), GE Healthcare (A Subsidiary of General Electric Company), Genedesign, Inc, Integrated Dna Technologies, Sigma-Aldrich Corporation, thermo Fisher Scientific Inc and Trilink Biotechnologies Inc Order a copy of this report at http://www.rnrmarketresearch.com/contacts/purchase?rname=208277 .

Apart from the comprehensive geographic and product analysis, and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by players in the industry over the last three years. In addition, the company profiles comprise the key players in the oligonucleotide synthesis market and their product portfolios, developments, and strategies. The above-mentioned market research data, current market size, and forecast of future trends will help key players and new entrants to make the necessary decisions regarding product offerings, geographic focus, change in strategic approach, R&D investments for innovations in products and technologies, and levels of output, in order to remain successful.

Reasons to Buy the Report:

The report will enable both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help the firms garner a greater market share. Firms purchasing the report can use any one or a combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares. Priced at US $4650 for a single user PDF, a discount on this research report can be requested at http://www.rnrmarketresearch.com/contacts/discount?rname=208277 .

Browse Related Report:

"Whole Exome Sequencing Market by Product (Systems, Kits (Library Preparation, Target Enrichment), by Services (Sequencing), by Technology (Sequencing by Synthesis), by Application (Cancer, Monogenic disorders) – Global Forecast to 2018” research report is now available with RnRMarketResearch.com. Companies like Illumina Inc, Thermo Fisher Scientific Inc, Beijing Genomics Institute (Bgi), Macrogen Inc, Eurofins Genomics Inc, Agilent Technologies Inc, Ambry Genetics, Genewiz Inc, Knome Inc, Roche Nimblegen Inc and Sengenics are discussed in this research available at http://www.rnrmarketresearch.com/whole-exome-sequencing-market-by-product-systems-kits-library-preparation-target-enrichment-by-services-sequencing-by-technology-sequencing-by-synthesis-by-application-cancer-monogenic-d-market-report.html .

"Molecular Biology Enzymes, Kits, & Reagents Market by Application (Cloning, Epigenetics, PCR, Restriction Digestion, Sequencing), Product (Ligase, Phosphatase, Polymerase, Protease, Restriction Endonuclease, Reverse Transcriptase) – Global Forecast to 2018" research report is now available with RnRMarketResearch.com. Companies like Affymetrix, Agilent Technologies, Enzymatics, Illumina, New England Biolabs, Qiagen, Roche, Sigma-Aldrich Co, Takara Bio Ltd and Changshu Thermo Fisher Scientific are discussed in this research available at http://www.rnrmarketresearch.com/molecular-biology-enzymes-kits-reagents-market-by-application-cloning-epigenetics-pcr-restriction-digestion-sequencing-product-ligase-phosphatase-polymerase-protease-restriction-endonu-market-report.html .

Explore more reports on biotechnology market at http://www.rnrmarketresearch.com/reports/life-sciences/biotechnology .

About Us:

RnRMarketResearch.com is an online database of syndicated market research reports covering over 5000+ micro markets (http://www.rnrmarketresearch.com/latest_reports ) including life sciences and its multiple sectors like biotechnology. Our database includes reports by leading publishers from across the globe. We provide 24/7 online and offline support service to our customers.

Read the full story at http://www.prweb.com/releases/oligonucleotide-synthesis/market-2019/prweb12135370.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related biology technology :

1. NITTO DENKO Avecia Inc. Introduces Dedicated Pre-Clinical Oligonucleotide Service, OliGrow
2. Whole Exome Sequencing Market by Product (Systems, Kits (Library Preparation, Target Enrichment), by Services (Sequencing), by Technology (Sequencing by Synthesis), by Application (Cancer, Monogenic disorders) - Global Forecast to 2018
3. Synthesis of structurally pure carbon nanotubes using molecular seeds
4. Cost-effective, solvothermal synthesis of heteroatom (S or N)-doped graphene developed
5. Advancements in High-Speed DNA Synthesis to Drive Growth in the Global Synthetic Biology Market, According to New Report by Global Industry Analysts, Inc.
6. Drug Discovery Using Natural Products - Optimization Studies of Inhibitors of Glucan Synthesis as Anti-Fungal Agents, New Life Science Webinar Hosted by Xtalks
7. CEM Introduces New Breakthrough Technology for Microwave Peptide Synthesis
8. Synthetic DNA Deemed Patentable by US Supreme Court, Gene Synthesis and Codon Optimization Provide Potential Pathway to Patentability
9. New Book Chapter from CEM on Microwave Peptide Synthesis
10. Monitoring Protein Synthesis One Codon at a Time Through Ribosome Profiling, a Webinar Hosted by Xtalks
11. Life Technologies Launches New Bioinformatics Software Platform Enabling Bio-Design and Gene Synthesis from Next Generation Sequencing Data
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/17/2017)... February 17, 2017 According ... by Product (Consumables, Service), Type (Safety, Efficacy, Validation), ... Drug Discovery and Development, Disease-Risk) - Global Forecast ... projected to reach USD 53.34 Billion by 2021 ... a CAGR of 13.8% during the forecast period ...
(Date:2/17/2017)... Feb. 17, 2017  Protagonist Therapeutics, Inc. (NASDAQ: ... its oral peptide drug candidates, PTG-100 and PTG-200, ... European Crohn,s and Colitis Organization (ECCO).  The ECCO ... Spain from February 15 – 18, ... data on Protagonist drug candidates PTG-100 and PTG-200. ...
(Date:2/16/2017)... and GREENWICH, Conn. ... private investment firm focused on venture growth investments ... promotion of Josh Richardson , M.D. to ... investments in biotechnology companies.  He is a board ... important roles in Longitude,s investments in Aimmune Therapeutics, ...
(Date:2/16/2017)... , Feb. 16, 2017   Capricor ... a clinical-stage biotechnology company developing first-in-class biological therapies ... that it has elected to terminate its license ... peptide receptor agonists, including Cenderitide. "Our ... move as we prioritize our efforts to advance ...
Breaking Biology Technology:
(Date:2/13/2017)... 13, 2017 Former 9/11 Commission border counsel ... Janice Kephart of Identity Strategy Partners, LLP, ... Trump,s "Executive Order: Protecting the Nation From Foreign ... "As President Trump,s ,Travel Ban, Executive Order ... essentially banned the travel ban, it is important that ...
(Date:2/9/2017)... Feb. 9, 2017 The biomass boiler market ... the biomass boiler market globally in terms of revenue ... boilers. The market for biomass boilers has been segmented ... application, and country/region. The market based on feedstock type, ... residues, biogas & energy crops, urban residues, and others. ...
(Date:2/8/2017)... -- Aware, Inc. (NASDAQ: AWRE ), a leading supplier ... its quarter and year ended December 31, 2016. ... million compared to $6.9 million in the same quarter last ... $0.6 million compared to $2.6 million in the fourth quarter ... was $0.5 million, or $0.02 per diluted share, which compares ...
Breaking Biology News(10 mins):